Newron Pharmaceuticals SpA Cash Flow Quality Index

Latest as of December 2024: -0.28x

Newron Pharmaceuticals SpA cash flow quality index. Newron Pharmaceuticals SpA (NWRN) has a Cash Flow Quality Index of -0.28x as of December 2024. Operating cash flow of CHF-8.79 Million is below net income of CHF30.95 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Newron Pharmaceuticals SpA to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.28x
Operating CF / Net Income

Operating Cash Flow

CHF-8.79 Million
CHF

Net Income

CHF30.95 Million
CHF

Data as of

Dec 2024
Most recent filing

Cash Flow Quality Index of Newron Pharmaceuticals SpA (2024–2024)

Cash flow quality index of Newron Pharmaceuticals SpA from 2024 to 2024. Historical Cash Flow Quality Index for Newron Pharmaceuticals SpA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Newron Pharmaceuticals SpA (NWRN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Newron Pharmaceuticals SpA Cash Flow Quality Index by Year (2024–2024)

Newron Pharmaceuticals SpA cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Newron Pharmaceuticals SpA. For the full cash flow conversion analysis, see Newron Pharmaceuticals SpA cash conversion from operations.

Year Quality Index Operating CF (CHF) Net Income YoY Change
2024 -0.82x CHF-17.61 Million CHF21.39 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.